✦ LIBER ✦

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study

✍ Scribed by Tabibian, J. H.; Weeding, E.; Jorgensen, R. A.; Petz, J. L.; Keach, J. C.; Talwalkar, J. A.; Lindor, K. D.

Book ID: 121677094
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 213 KB
Volume: 37
Category: Article
ISSN: 0269-2813
DOI: 10.1111/apt.12232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined immunosuppressive therapy with

Combined immunosuppressive therapy with azathioprine and prednisone in patients with primary sclerosing cholangitis - a pilot study

✍ C. Schramm; E. Pascher; I. Helmreich-Becker; G. Gerken; K.H. Meyer zum Büschenfe 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 170 KB

W1849 Minocyline in the Treatment of Pat

W1849 Minocyline in the Treatment of Patients with Primary Sclerosing Cholangitis: Results of a Pilot Study

✍ Silveira, Marina; Gossard, Andrea A.; Jorgensen, Roberta A.; Keach, Jill C.; Pet 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Budesonide or prednisone in combination

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study

✍ H.J.F van Hoogstraten; F.P Vleggaar; G.J Boland; W van Steenbergen; P Griffioen; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

Metabolomic profiling of 17 bile acids i

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study

✍ Jocelyn Trottier; Andrzej Białek; Patrick Caron; Robert J. Straka; Jenny Heathco 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 648 KB

Risk factors and clinical presentation o

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study

✍ Annika Bergquist; Hans Glaumann; Bo Persson; Ulrika Broomé 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The reason why 10% to 20% of all patients with primary sclerosing cholangitis (PSC) develop cholangiocarcinoma (CC) remains unknown. The aim of this study was to compare the clinical and biochemical presentation in PSC patients with and without hepatobiliary malignancy and to look for risk factors f

Transforming Growth Factor-β (TGF-β) Pro

Transforming Growth Factor-β (TGF-β) Protein Levels Are Not Elevated in the Blood or Bile of Patients with Primary Sclerosing Cholangitis: A Pilot Study

✍ Jk. Watt; K. Hawkins; M. Zhang; J. Lipschitz; G. Sandha; Y. Gong; J. Uhanova; G. 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 90 KB